PillRx only · Tablet, Chewable · Oral
Lanthanum Carbonate
Brands: Fosrenol · Lanthanum Carbonate
7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US21 NDCs
7 active makers
7 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers7 labelers
Packages24
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$3.125
Latest avg · Jun 17, 2026
-31%
Since Dec 17, 2025
7
Active US suppliers
38%
Top-2 supplier share*
Who makes it7 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | unknown | 6 | SUPPLYING |
| Exelan Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Takeda Pharmaceuticals America, Inc. | unknown | 3 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | unknown | 3 | SUPPLYING |
| Prasco Laboratories | unknown | 3 | SUPPLYING |
| Ascend Laboratories, LLC | unknown | 3 | SUPPLYING |
| Cipla USA Inc. | unknown | 3 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.